Andrew L Pecora - Net Worth and Insider Trading

Andrew L Pecora Net Worth

The estimated net worth of Andrew L Pecora is at least $7,118 dollars as of 2024-05-11. Andrew L Pecora is the Chief Visionary Officer of Lisata Therapeutics Inc and owns about 2,288 shares of Lisata Therapeutics Inc (LSTA) stock worth over $6,749. Andrew L Pecora is also the Director of Cancer Genetics Inc and owns about 80 shares of Cancer Genetics Inc (CGIX) stock worth over $369. Details can be seen in Andrew L Pecora's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew L Pecora has not made any transactions after 2014-11-24 and currently still holds the listed stock(s).

Transaction Summary of Andrew L Pecora

To

Andrew L Pecora Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew L Pecora owns 5 companies in total, including Lisata Therapeutics Inc (LSTA) , TetraLogic Pharmaceuticals Corp (TLOG) , and Cancer Genetics Inc (CGIX) among others .

Click here to see the complete history of Andrew L Pecora’s form 4 insider trades.

Insider Ownership Summary of Andrew L Pecora

Ticker Comapny Transaction Date Type of Owner
LSTA Lisata Therapeutics Inc 2014-11-24 See Remarks
TLOG TetraLogic Pharmaceuticals Corp 2015-07-10 director
CGIX Cancer Genetics Inc 2013-11-18 director
2013-10-10 director
2021-09-15 President

Andrew L Pecora Latest Holdings Summary

Andrew L Pecora currently owns a total of 2 stocks. Among these stocks, Andrew L Pecora owns 2,288 shares of Lisata Therapeutics Inc (LSTA) as of November 24, 2014, with a value of $6,749 and a weighting of 94.82%. Andrew L Pecora also owns 80 shares of Cancer Genetics Inc (CGIX) as of November 18, 2013, with a value of $369 and a weighting of 5.18%.

Latest Holdings of Andrew L Pecora

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LSTA Lisata Therapeutics Inc 2014-11-24 2,288 2.95 6,749
CGIX Cancer Genetics Inc 2013-11-18 80 4.61 369

Holding Weightings of Andrew L Pecora


Andrew L Pecora Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew L Pecora has made a total of 0 transactions in Lisata Therapeutics Inc (LSTA) over the past 5 years. The most-recent trade in Lisata Therapeutics Inc is the acquisition of 83 shares on November 24, 2014, which cost Andrew L Pecora around $50,125.

According to the SEC Form 4 filings, Andrew L Pecora has made a total of 0 transactions in Cancer Genetics Inc (CGIX) over the past 5 years. The most-recent trade in Cancer Genetics Inc is the sale of 1,667 shares on November 18, 2013, which brought Andrew L Pecora around $713,500.

Insider Trading History of Andrew L Pecora

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew L Pecora Trading Performance

GuruFocus tracks the stock performance after each of Andrew L Pecora's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew L Pecora is -3.47%. GuruFocus also compares Andrew L Pecora's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew L Pecora within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew L Pecora's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew L Pecora

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -19.06
Relative Return to S&P 500(%) -19.66

Andrew L Pecora Ownership Network

Ownership Network List of Andrew L Pecora

No Data

Ownership Network Relation of Andrew L Pecora


Andrew L Pecora Owned Company Details

What does Lisata Therapeutics Inc do?

Who are the key executives at Lisata Therapeutics Inc?

Andrew L Pecora is the See Remarks of Lisata Therapeutics Inc. Other key executives at Lisata Therapeutics Inc include director & President & CBO David W. Slack , EVP & R&D and CMO Kristen K Buck , and CLO & SVP of Corp Dev Todd C Girolamo .

Lisata Therapeutics Inc (LSTA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Lisata Therapeutics Inc (LSTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lisata Therapeutics Inc (LSTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Lisata Therapeutics Inc (LSTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lisata Therapeutics Inc Insider Transactions

No Available Data

Andrew L Pecora Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew L Pecora. You might contact Andrew L Pecora via mailing address: C/o Neostem, Inc., 420 Lexington Avenue, Suite 450, New York Ny 10170.

Discussions on Andrew L Pecora

No discussions yet.